Tetrous' portfolio of regenative medicine solutions are manufactured exclusively for Tetrous by Origin Biologics (NY, USA) and Australian Biotechnologies (Sydney, Australia).
Additionally, Tetrous is partnered with Australian Biotechnologies who sell products utilizing Tetrous' technology under license in Australia.
Tetrous believes strongly in the power of partnerships to progress science and product development and seeks mutually rewarding partnerships.
Contact us to discuss partnering your technology, or any other partnership opportunities.
Bone Fiber Technology For Spine and Orthopedic Markets
TheraCell, Inc. is a regenerative medicine company which is guided by a team of influential spine surgeons, and regenerative medicine scientists, and led by experienced Medical Device executives. TheraCell has developed the next generation of advanced technologies for orthopedic tissue repair. The first of these is a proprietary and patented process for making demineralized bone fibers (DBF™). The second platform is a patented process for infusing demineralized cortical bone powder into cancellous bone to enhance the osteoinductivity of demineralized cancellous bone grafts. The third technology platform is a range of proprietary and patented oxygenation technologies. Oxygenation leads to improved tissue regeneration. TheraCell has developed methodologies and gained patent protection for applying the oxygenation technology to demineralized bone matrix products and other biologic materials. www.theracellinc.com DBF™ is a trademark of TheraCell.
DermOQ, Inc. is a skincare brand that brings the latest advances in oxygenated skincare from the world-renowned scientists who are revolutionizing tissue repair with oxygen. DermOQ, Inc. has developed a proprietary MaxOx™ oxygen delivery system for supplying molecular oxygen and other active nutrients into the skin to keep it in its most dynamic and alive state. Our patent pending innovative oxygen delivery systems use highly soluble oxygen compounds enhanced with molecular oxygen to penetrate and replenish the skin, delaying and reversing the effects of aging. Founded in 2017, the brand is headquartered in Los Angeles and maintains offices, laboratories and production facilities in the Boston area. www.dermoq.com. MaxOx™ is a trademark of DermOQ.